ad

8436 大江生醫


  • EPS 年複合成長率: 17.54% (109-105)
  • 營業利益年複合成長率: 26.5% (109-105)
  • 本益比: 20.7
  • 近四季EPS總合: 15.8 (3.25,3.82,4.23,4.5)
  • 融資餘額佔股本比例:2.44%
  • 融資使用率: 9.76%
  • 近期收盤價: 327.0 (2021-07-30)

營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近5年

20202019201820172016
營業毛利率43.6541.9843.4340.6341.56
營業利益率24.5423.0225.1521.6020.03
折舊負擔比率3.892.671.992.632.93
稅前淨利率26.7325.1427.2521.8720.42
股東權益報酬率25.0431.4139.3523.2520.39
資產報酬率16.3519.3423.9516.5414.63
本業收入比91.8191.5692.3098.7698.11
業外獲益比8.198.447.701.241.89
無形資產佔淨值比0.180.290.240.000.00




營業毛利率,營業利益率,稅前淨利率,股東權益報酬率-近8季

2021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
營業毛利率44.8541.1245.4543.8744.1141.2040.2343.33
營業利益率21.9824.1624.7025.9323.0719.1817.3826.66
折舊負擔比率4.734.183.763.584.102.883.332.40
稅前淨利率24.3926.9428.3426.2025.2221.3120.8427.61
股東權益報酬率4.946.167.527.805.255.925.549.74
資產報酬率3.143.874.454.823.533.823.335.84
本業收入比90.1189.5387.2398.9691.4390.1283.3396.49
業外獲益比9.8910.2912.931.048.579.8816.673.37
無形資產佔淨值比0.180.180.220.260.310.290.250.22




現金流量-近5年 (儘量避開近3年累計小於0的公司)

20202019201820172016
營運現金流量(百萬)2697146635101016885
自由現金流量(百萬)1753422184266207
稅後淨利(百萬)183920161795712516




現金流量-近8季

2021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
營運現金流量(百萬)279733773115337272674723
自由現金流量(百萬)-1083396754932-330155406307
稅後淨利(百萬)381448494524372408361624




成長能力-近5年

20202019201820172016
EPS(完全稀釋)15.3716.6317.328.116.85
EPS成長率(%)-7.58-3.98113.5618.3974.30
營業利益(百萬)201822022037879623
營業利益成長率(%)-8.368.10131.7441.09132.46




成長能力-近4季

2021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
EPS(完全稀釋)3.253.824.234.503.133.443.046.08
去年同期EPS成長率(%)3.8311.0539.14-25.99----
營業利益(百萬)428496533572416447360688
去年同期營業利益成長率(%)2.8810.9648.06-16.86----




營收年增率

2021-62021-52021-42021-32021-1~22020-12
8.070.869.111.855.08-9.34

稅前淨利較去年同期

2021Q1(百萬)2020Q1(百萬)YoY(%)
475.0455.04.3956
2020Q4(百萬)2019Q4(百萬)YoY(%)
554.0496.011.693
2020Q3(百萬)2019Q3(百萬)YoY(%)
611.0432.041.435

EPS較上季

2021Q1(元)2020Q4(元)比率
3.253.82-0.149

應收帳周轉率和存貨周轉率-近5年

20202019201820172016
應收帳款周轉率13.1916.5816.4112.9116.36
存貨周轉率5.354.645.185.454.98




應收帳周轉率和存貨周轉率-近8季

2021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
應收帳款周轉率2.873.083.033.052.714.203.042.82
存貨周轉率1.561.781.581.370.951.211.031.18




償債能力-近5年

20202019201820172016
負債比0.370.330.440.290.29
金融負債(百萬)151420012143238
營業收入淨額(百萬)82249566809840723110
利息保障倍數162.96484.56464.27339.72154.69
長期銀行借款占稅後淨利比0.000.000.000.190.27




償債能力-近8季

2021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
負債比0.380.370.390.440.330.330.380.42
金融負債(百萬)18191514151311694532005000
營業收入淨額(百萬)19462055215722071805232920712582
利息保障倍數111.37179.16128.37167.59208.28394.63346.2320364.30
長期銀行借款占稅後淨利比1.380.010.010.010.010.000.000.00




成本指標-近5年

20202019201820172016
營業收入淨額(百萬)82249566809840723110
推銷費用(百萬)505606509263220
管理費用(百萬)591694493330289
研究發展費(百萬)497511438182160
推銷費用率(%)6.146.336.296.467.07
管理費用率(%)7.197.256.098.109.29
研究發展費用率(%)6.045.345.414.475.14




成本指標-近8季

2021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
營業收入淨額(百萬)19462055215722071805232920712582
推銷費用(百萬)179109142127127157154157
管理費用(百萬)146148156148140210184155
研究發展費(百萬)121113150121113146134119
推銷費用率(%)9.205.306.585.757.046.747.446.08
管理費用率(%)7.507.207.236.717.769.028.886.00
研究發展費用率(%)6.225.506.955.486.266.276.474.61




財務健檢燈號

上市滿三年資本額10億以上股本形成中現金增資比率低於50%負債比率低於50%董監持股設質低於10%現金(含約當現金)占股本超過50%過去4季累積正營運現金流量過去4季ROE超過25%過去6個月的營收維持正的年成長率過去4季的EPS年增率是正數
OOOOOOOXXX
8年11.82億23.05%37.52%0.0%341.96%2938百萬19.76%

融資使用率

日期股價融資使用率
2021-07-30327.09.76%
2021-07-29331.59.63%
2021-07-28336.09.23%
2021-07-27334.010.15%
2021-07-26330.012.69%
2021-07-23300.011.72%
2021-07-22290.012.17%
2021-07-21289.012.30%
2021-07-20283.012.62%
2021-07-19270.513.10%
2021-07-16264.513.87%
2021-07-15267.512.69%
2021-07-14255.013.16%
2021-07-13254.513.24%
2021-07-12258.513.24%
2021-07-09250.013.11%
2021-07-08255.013.33%
2021-07-07253.013.09%
2021-07-06254.013.15%
2021-07-05255.013.17%
2021-07-02251.013.25%
2021-07-01248.013.61%
2021-06-30257.013.67%
2021-06-29257.013.63%
2021-06-28263.513.43%
2021-06-25265.013.09%
2021-06-24264.013.24%
2021-06-23252.012.78%
2021-06-22241.511.95%
2021-06-21239.512.22%



沒有留言:

張貼留言